Glycylproline Dipeptidyl Aminopeptidase Test Kits Manufacturers

Home / Product / Liver Function / 【GPDA】Glycylproline Dipeptidyl Aminopeptidase Assay Kit (Continuous Monitoring Method)
  • detail of 【GPDA】Glycylproline Dipeptidyl Aminopeptidase Assay Kit (Continuous Monitoring Method)
  • detail of 【GPDA】Glycylproline Dipeptidyl Aminopeptidase Assay Kit (Continuous Monitoring Method)
  • detail of 【GPDA】Glycylproline Dipeptidyl Aminopeptidase Assay Kit (Continuous Monitoring Method)
  • detail of 【GPDA】Glycylproline Dipeptidyl Aminopeptidase Assay Kit (Continuous Monitoring Method)
  • detail of 【GPDA】Glycylproline Dipeptidyl Aminopeptidase Assay Kit (Continuous Monitoring Method)
  • detail of 【GPDA】Glycylproline Dipeptidyl Aminopeptidase Assay Kit (Continuous Monitoring Method)

【GPDA】Glycylproline Dipeptidyl Aminopeptidase Assay Kit (Continuous Monitoring Method)

Usage

This kit is used to quantitatively detect the activity of glycylproline dipeptidyl aminopeptidase in human serum in vitro.

 

Background of Clinical Indications

It is used for the auxiliary diagnosis of liver disorders and gastrointestinal diseases, etc. Increased serum GPDA: seen in patients with secondary hepatic disorders. For patients with drug-induced liver injury or primary hepatic cirrhosis caused by intrahepatic cholestasis, serum GPDA is increased significantly. Decreased serum GPDA: seen in patients with gastric disease, duodenal disease; rheumatoid arthritis, generalized lupus erythematosus. The activity of GPDA in urine of patients with chronic glomerulonephritis is increased significantly.

Contact Us    PDF Download    

Packing category

Item No. Specification (Reagent 1) Specification (Reagent 2) Packing category
A002-a 45 x 1 6.5 x 1 7170
A002-a11 45 x 2 6.5 x 2 7170 Double
A002-a12 68 x 2 10 x 2 7170 Big package
A002-b 45 x 1 6.5 x 1 7060
A002-b12 68 x 4 40 x 1 7060 Big package
A002-c 45 x 2 6.5 x 2 Beckman CX series/LX20 series/DXC600/800 series、AU series etc.
A002-d 45 x 2 6.5 x 2 TBA 120FR/TBA 2000FR/TBA40FR

Feedback